Skip to main content
Erschienen in: International Journal of Colorectal Disease 1/2008

01.01.2008 | Original Article

Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients

verfasst von: Chang-Ho Jeon, Han-IL Lee, Im-Hee Shin, Jong-Wook Park

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Background and aim

Colorectal cancer (CRC) is one of the most rapidly increasing cancers in Korea, but no comprehensive analysis has been performed to speculate the genetic basis of CRC development. We investigated the presence of adenomatous polyposis coli gene (APC), Kirsten-ras (K-ras), p53, microsatellite instability (MSI), and melanoma antigen gene (MAGE) alterations in CRC and correlated the results obtained with clinical data.

Materials and methods

We collected 78 cancer tissues from CRC patients. Genetic analyses were performed on APC, K-ras, p53, and MSI (BAT 25 and BAT 26), and in addition, MAGE expression was tested by reverse transcription polymerase chain reaction. Correlations between genetic markers and clinical factors were analyzed after reviewing medical records.

Result

The positive rates for alterations of APC, K-ras, p53, MSI, and MAGE in 78 tissue samples were 33.3, 29.5, 34.6, 9.0, and 68.4%, respectively. Mutations were frequently detected in codons 1291 and 1450 of APC, in codon 12 of K-ras and in codons 248, 282, and 176 of p53. APC mutations were frequently noted in early-stage cancer, whereas MSI was observed in right-sided and multiple cancers. No associations were found between the presence of alterations in APC, K-ras, p53, MSI, and MAGE.

Interpretation

In Koreans, positive rates of alterations in APC and p53 were slightly lower than those of APC and p53 in Caucasians, and the genetic alterations including MAGE expression are involved in 92.1% of CRCs. The lack of multiple mutations and of a relation between mutation rates and clinical stage suggest that genetic alterations might have independent influences on CRC development in Koreans.
Literatur
1.
Zurück zum Zitat Goh KL, Quek KF, Yeo GTS, Hilmi IN, Lee CK, Hasnida N, Aznan M, Kwan KL, Ong KT (2005) Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther 22:859–864PubMedCrossRef Goh KL, Quek KF, Yeo GTS, Hilmi IN, Lee CK, Hasnida N, Aznan M, Kwan KL, Ong KT (2005) Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther 22:859–864PubMedCrossRef
2.
3.
Zurück zum Zitat Kim JP, Park IS, Ahn YO, Shin MH, Ahn DH, Kang TW, Ko UR, Ku PS, Kim KY, Kim KH, Kim NK, Kim DJ, Kim DH, Kim BS, Kim SH, Park CT, Min JS, Park TK, Woo BH, Yoo H, Lee SW, Lee SJ, Cho KS, Joo HZ, Ham EK (1995) 1991 Cancer incidence in Seoul, Korea: results of the implementation study of the Seoul cancer registry. J Korean Med Sci 10:74–84PubMed Kim JP, Park IS, Ahn YO, Shin MH, Ahn DH, Kang TW, Ko UR, Ku PS, Kim KY, Kim KH, Kim NK, Kim DJ, Kim DH, Kim BS, Kim SH, Park CT, Min JS, Park TK, Woo BH, Yoo H, Lee SW, Lee SJ, Cho KS, Joo HZ, Ham EK (1995) 1991 Cancer incidence in Seoul, Korea: results of the implementation study of the Seoul cancer registry. J Korean Med Sci 10:74–84PubMed
4.
Zurück zum Zitat Kim DH, Shin MH, Ahn YO (2000) Incidence pattern of colorectal cancer in Korea by subsite origin. J Korean Med Sci 15:675–681PubMed Kim DH, Shin MH, Ahn YO (2000) Incidence pattern of colorectal cancer in Korea by subsite origin. J Korean Med Sci 15:675–681PubMed
5.
Zurück zum Zitat Suh CI, Suh KA, Park SH, Chang HJ, Ko JW, Ahn DH (2000) Annual report of the central cancer registry in Korea—1998. J Korean Cancer Assoc 32:827–834 Suh CI, Suh KA, Park SH, Chang HJ, Ko JW, Ahn DH (2000) Annual report of the central cancer registry in Korea—1998. J Korean Cancer Assoc 32:827–834
6.
Zurück zum Zitat Shin HR, Jung KW, Won YJ, Park JG (2004) 2002 Annual report of the Korea central cancer registry: based on registered data from 139 hospitals. Cancer Res Treat 36:93–99 Shin HR, Jung KW, Won YJ, Park JG (2004) 2002 Annual report of the Korea central cancer registry: based on registered data from 139 hospitals. Cancer Res Treat 36:93–99
7.
Zurück zum Zitat Vogelstein B, Kinzler KW (2002) The genetic basis human cancer. In: Kinzler KW, Vogelstin B (eds) Colorectal cancers. McGraw-Hill, New York, pp 587–593 Vogelstein B, Kinzler KW (2002) The genetic basis human cancer. In: Kinzler KW, Vogelstin B (eds) Colorectal cancers. McGraw-Hill, New York, pp 587–593
8.
Zurück zum Zitat Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR (2002) Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. PNAS 99:9433–9438PubMed Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR (2002) Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. PNAS 99:9433–9438PubMed
9.
Zurück zum Zitat Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532PubMedCrossRef Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532PubMedCrossRef
10.
Zurück zum Zitat Jeong SY, Shin KH, Shin JH, Ku JL, Shin YK, Park SY, Kim WH, Park JG (2003) Microsatellite instability and mutations in DNA mismatch repair genes in sporadic colorectal cancers. Dis Colon Rectum 46:1069–1077PubMedCrossRef Jeong SY, Shin KH, Shin JH, Ku JL, Shin YK, Park SY, Kim WH, Park JG (2003) Microsatellite instability and mutations in DNA mismatch repair genes in sporadic colorectal cancers. Dis Colon Rectum 46:1069–1077PubMedCrossRef
11.
Zurück zum Zitat Bruggen P, Traversari C, Chomez P, Lurquin C, Plaen E, Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 13:1643–1647CrossRef Bruggen P, Traversari C, Chomez P, Lurquin C, Plaen E, Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 13:1643–1647CrossRef
12.
Zurück zum Zitat Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, Smet C, Brasseur F, Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomez P, Backer O, Cavenee W, Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40:360–369PubMedCrossRef Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, Smet C, Brasseur F, Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomez P, Backer O, Cavenee W, Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40:360–369PubMedCrossRef
13.
Zurück zum Zitat Park MS, Park JW, Jeon CH, Lee KD, Chang HK (2002) Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to A6 in colorectal carcinomas among Koreans. J Korean Med Sci 17:497–501PubMed Park MS, Park JW, Jeon CH, Lee KD, Chang HK (2002) Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to A6 in colorectal carcinomas among Koreans. J Korean Med Sci 17:497–501PubMed
14.
Zurück zum Zitat Kim KH, Choi JS, Kim IJ, Ku JL, Park JG (2006) Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. World J Gastroenterol 21:5651–5657 Kim KH, Choi JS, Kim IJ, Ku JL, Park JG (2006) Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. World J Gastroenterol 21:5651–5657
15.
Zurück zum Zitat Fearnhead NS, Wilding JL, Bodmer WF (2002) Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 64:27–43PubMedCrossRef Fearnhead NS, Wilding JL, Bodmer WF (2002) Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 64:27–43PubMedCrossRef
16.
18.
Zurück zum Zitat Park JW, Kwon TK, Kim IH, Sohn SS, Kim YS, Kim CI, Bae OS, Lee KS, Lee KD, Lee CS, Chang HK, Choe BK, Ahn YS, Jeon CH (2002) A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods 266:79–86PubMedCrossRef Park JW, Kwon TK, Kim IH, Sohn SS, Kim YS, Kim CI, Bae OS, Lee KS, Lee KD, Lee CS, Chang HK, Choe BK, Ahn YS, Jeon CH (2002) A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods 266:79–86PubMedCrossRef
19.
Zurück zum Zitat Dietmaier W, Hofstadter F (2001) Detection of microsatellite instability by real time PCR and hybridization probe melting point analysis. Lab Invest 81:1453–1456PubMed Dietmaier W, Hofstadter F (2001) Detection of microsatellite instability by real time PCR and hybridization probe melting point analysis. Lab Invest 81:1453–1456PubMed
20.
Zurück zum Zitat Won YJ, Park KJ, Kwon HJ, Lee JH, Kim JH, Kim YJ, Chun SH, Han HJ, Park JG (1999) Germline mutations of the APC gene in Korean familial adenomatous polyposis patients. J Hum Genet 44:103–108PubMedCrossRef Won YJ, Park KJ, Kwon HJ, Lee JH, Kim JH, Kim YJ, Chun SH, Han HJ, Park JG (1999) Germline mutations of the APC gene in Korean familial adenomatous polyposis patients. J Hum Genet 44:103–108PubMedCrossRef
21.
Zurück zum Zitat Hutter P, Rey-Berthod C, Chappuis PO (2001) Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis. Human Mutat 18:550CrossRef Hutter P, Rey-Berthod C, Chappuis PO (2001) Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis. Human Mutat 18:550CrossRef
22.
Zurück zum Zitat Gavert N, Yaron Y, Maiman T, Bercovich D, Rozen P, Shomrat R, Legum C Orr-Urtreger A (2002) Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Human Mutat 19:664CrossRef Gavert N, Yaron Y, Maiman T, Bercovich D, Rozen P, Shomrat R, Legum C Orr-Urtreger A (2002) Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Human Mutat 19:664CrossRef
23.
Zurück zum Zitat Luijt RB, Khan PM, Vasen HFA, Tops CMJ, Leeuwen-Cornelisse ISJ, Wijnen JT, Klift HM, Plug RJ, Griffioen G, Fodde G (1997) Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern Analysis. Human Mutat 9:7–16CrossRef Luijt RB, Khan PM, Vasen HFA, Tops CMJ, Leeuwen-Cornelisse ISJ, Wijnen JT, Klift HM, Plug RJ, Griffioen G, Fodde G (1997) Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern Analysis. Human Mutat 9:7–16CrossRef
24.
Zurück zum Zitat Calistri D, Rengucci C, Seymour I, Lattuneddu A, Polifemo A, Monti F, Saragoni L, Amadori D (2005) Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. J Cell Physiol 204:484–488PubMedCrossRef Calistri D, Rengucci C, Seymour I, Lattuneddu A, Polifemo A, Monti F, Saragoni L, Amadori D (2005) Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. J Cell Physiol 204:484–488PubMedCrossRef
25.
Zurück zum Zitat Oh HE, Cho SJ, Won NH, Lee D, Kim I, Yeom BW (2001) K-ras gene mutations and expression of K-ras, p16, cyclin D1 and p53 in synchronous lesions of the colon adenoma carcinoma sequences. Korean J Pathol 35:291–298 Oh HE, Cho SJ, Won NH, Lee D, Kim I, Yeom BW (2001) K-ras gene mutations and expression of K-ras, p16, cyclin D1 and p53 in synchronous lesions of the colon adenoma carcinoma sequences. Korean J Pathol 35:291–298
26.
Zurück zum Zitat Oliver M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Human Mutat 19:607–614CrossRef Oliver M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Human Mutat 19:607–614CrossRef
27.
Zurück zum Zitat Hong SI, Hong WS, Jang JJ, Lee DS, Cho NS, Jung ME, Kim HB, Ha GW, Park IC, Cho DS (1994) Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res 14:1251–1255PubMed Hong SI, Hong WS, Jang JJ, Lee DS, Cho NS, Jung ME, Kim HB, Ha GW, Park IC, Cho DS (1994) Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res 14:1251–1255PubMed
28.
Zurück zum Zitat Alves PM, Levy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M, Vuilleumier H, Givel JC, Halkic N, Speiser DE, Romero P, Levy F (2007) Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother 56:839–847PubMedCrossRef Alves PM, Levy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M, Vuilleumier H, Givel JC, Halkic N, Speiser DE, Romero P, Levy F (2007) Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother 56:839–847PubMedCrossRef
29.
Zurück zum Zitat Koketsu S, Watanabe T, Kazama S, Ishihara S, Komuro Y, Nagawa H (2004) What types of colorectal cancer overexpress the MAGE protein? Hepatogastroenterology 51:1648–1652PubMed Koketsu S, Watanabe T, Kazama S, Ishihara S, Komuro Y, Nagawa H (2004) What types of colorectal cancer overexpress the MAGE protein? Hepatogastroenterology 51:1648–1652PubMed
31.
Zurück zum Zitat Muta H, Noguchi M, Perucho M, Ushio K, Sugihara K, Ochiai A, Nawata J, Hirohashi S (1996) Clinical implications of microsatellite instability in colorectal cancers. Cancer 77:265–270PubMedCrossRef Muta H, Noguchi M, Perucho M, Ushio K, Sugihara K, Ochiai A, Nawata J, Hirohashi S (1996) Clinical implications of microsatellite instability in colorectal cancers. Cancer 77:265–270PubMedCrossRef
32.
Zurück zum Zitat Ruschoff J, Bocker T, Schlegel J, Stumm G, Hofstaedter F (1995) Microsatellite instability: new aspects in the carcinogenesis of colorectal carcinoma. Virchows Arch 426:215–222PubMedCrossRef Ruschoff J, Bocker T, Schlegel J, Stumm G, Hofstaedter F (1995) Microsatellite instability: new aspects in the carcinogenesis of colorectal carcinoma. Virchows Arch 426:215–222PubMedCrossRef
33.
Zurück zum Zitat Cravo ML, Fidalgo PO, Lage PA, Albuquerque CM, Chaves PP, Claro I, Gomes T, Gaspar C, Soares JO, Nobre-Leitao C (1999) Validation and simplification of Bethesda guidelines for identifying apparently sporadic forms of colorectal carcinoma with microsatellite instability. Cancer 85:779–785PubMedCrossRef Cravo ML, Fidalgo PO, Lage PA, Albuquerque CM, Chaves PP, Claro I, Gomes T, Gaspar C, Soares JO, Nobre-Leitao C (1999) Validation and simplification of Bethesda guidelines for identifying apparently sporadic forms of colorectal carcinoma with microsatellite instability. Cancer 85:779–785PubMedCrossRef
Metadaten
Titel
Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients
verfasst von
Chang-Ho Jeon
Han-IL Lee
Im-Hee Shin
Jong-Wook Park
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2008
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-007-0373-0

Weitere Artikel der Ausgabe 1/2008

International Journal of Colorectal Disease 1/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.